EUVIMEDEUVIMED entdecken
Crossref

Xpert MTB/RIF Ultra as a diagnostic tool for pleural tuberculosis: a study at Indian tertiary care centre

Sumedha Sharma iD, Prabhdeep Kaur, Ashutosh N Aggarwal, Khushpreet Kaur, Rakesh Yadav, Sunil Sethi, Indu Verma

Letters in Applied Microbiology · 2024

DOI: 10.1093/lambio/ovae102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2024. Verfasst von Sumedha Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India. Hauptthemen laut MEDLINE: Tuberculosis, Pleural, Tertiary Care Centers, Mycobacterium tuberculosis, Sensitivity and Specificity. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the advent of Xpert MTB/RIF, pleural tuberculosis (TB) diagnosis in pleural fluid is still difficult. Hence, we assessed the diagnostic efficacy of its advanced version, Xpert MTB/RIF Ultra, for pleural TB diagnosis using pleural fluid as a sample. Tuberculosis pleuritis (TBP) suspects (n = 261) were enrolled in the study, of which 29 were excluded. The remaining patients (n = 232) were categorized into definite TBP (n = 31), probable TBP (n = 28), and non-TB controls (n = 173) based on the composite reference standard consisting of smear, culture, histopathology, and Xpert MTB/RIF as well as follow-up/clinical response to anti-TB therapy. Among the TBP suspects, 59 were diagnosed as TBP patients. The sensitivity of Xpert MTB/RIF Ultra (52.5%) using pleural fluid for TBP diagnosis was higher than sensitivity obtained with smear (22.4%), culture (17.6%), and Xpert MTB/RIF (25%) alone, carried out using either pleural fluid or pleural biopsy or both the samples. In cases of probable TBP, where none of the laboratory tests were positive, Xpert MTB/RIF Ultra use led to an increased diagnostic percentage of definite TBP from 52.5% to 69.4%. Overall, Xpert MTB/RIF Ultra showed promising results for a definitive diagnosis of TBP in pleural fluid samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, PleuralTertiary Care CentersMycobacterium tuberculosisSensitivity and SpecificityHumansIndiaMaleFemaleAdultMiddle AgedAgedPleural EffusionMolecular Diagnostic Techniques

Stichwörter der Autor:innen

Xpert MTB/RIF Ultradiagnostic efficacypleural fluidpleural tuberculosis

Autor:innen und Institutionen

  • Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
  • Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
  • Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.

ORCID-Profile: Sumedha Sharma

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Sharma, S., Kaur, P., Aggarwal, A. N., Kaur, K., Yadav, R., Sethi, S., & Verma, I. (2024). Xpert MTB/RIF Ultra as a diagnostic tool for pleural tuberculosis: a study at Indian tertiary care centre. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovae102

Vancouver

Sharma S, Kaur P, Aggarwal AN, Kaur K, Yadav R, Sethi S, et al. Xpert MTB/RIF Ultra as a diagnostic tool for pleural tuberculosis: a study at Indian tertiary care centre. Letters in Applied Microbiology. 2024. doi:10.1093/lambio/ovae102

BibTeX
@article{Sharma2024,
  author = {Sharma, Sumedha and Kaur, Prabhdeep and Aggarwal, Ashutosh N and Kaur, Khushpreet and Yadav, Rakesh and Sethi, Sunil and Verma, Indu},
  title = {Xpert MTB/RIF Ultra as a diagnostic tool for pleural tuberculosis: a study at Indian tertiary care centre},
  journal = {Letters in Applied Microbiology},
  year = {2024},
  doi = {10.1093/lambio/ovae102}
}
Kostenlos starten →